2.0
22 Jan 2026
Former employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Exposure to international projects and pharmaceutical clients.
Cons
Poor communication and lack of transparency from management. Unclear planning, frequent last-minute changes.